Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(13 sites)
United States
Banner MD Anderson Cancer Center, Gilbert, Arizona The University of Arizona Cancer Center - North Campus, Tucson, Arizona Sylvester Comprehensive Cancer Center, Miami, Florida Miami Cancer Institute, Miami, Florida The John Hopkins University School of Medicine, Baltimore, Maryland